What is Advanced Clinical?
Advanced Clinical operates as a specialized clinical research organization, delivering comprehensive solutions to pharmaceutical, biological, and medical device developers. The company distinguishes itself through a patient-centric framework that emphasizes the human element of clinical trials, ensuring that research progress is balanced with the quality of life for participants. By fostering deep collaborations with research sites, advocacy groups, and vendors, Advanced Clinical has established a robust infrastructure that facilitates complex trial management and regulatory compliance. Their market position is defined by a commitment to operational excellence and a unique service model that bridges the gap between technical clinical requirements and the ethical imperatives of patient care.
How much funding has Advanced Clinical raised?
Advanced Clinical has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in Advanced Clinical
PPP
Public-Private Partnership
What's next for Advanced Clinical?
With this recent capital deployment, Advanced Clinical is well-positioned to scale its enterprise-level operations and expand its footprint in the global clinical research market. The strategic focus will likely shift toward enhancing digital trial capabilities and deepening partnerships with key stakeholders to streamline the drug development lifecycle. As the industry moves toward more decentralized and patient-focused research models, the firm is poised to leverage its current financial standing to invest in proprietary technologies and talent acquisition. This growth trajectory suggests a long-term commitment to maintaining high standards of clinical integrity while navigating the evolving regulatory and technological demands of the life sciences sector.
See full Advanced Clinical company page
